SHANGHAI – In its seventh year, the Chinabio Partnering Forum is the most active partnering event in China, akin to the J.P. Morgan Healthcare Conference. Even after a tough year for Western companies with corruption probes rattling the industry and regulatory hurdles inching ever higher, "Big pharmas are still committed to China," said Greg Scott, founder and chairman of the Chinabio Group in his keynote address. "Partnering activity is definitely on the rise."